Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.03 | 0.7 |
mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.7 |
mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |